Brief: Sigilon Therapeutics Posts Quarterly Loss Per Share Of $0.60

Sigilon Therapeutics

10/05/2021 22:29

May 10 (Reuters) - Sigilon Therapeutics Inc  SGTX.O :
    * SIGILON THERAPEUTICS REPORTS FIRST QUARTER 2021 FINANCIAL
RESULTS AND BUSINESS HIGHLIGHTS
    * SIGILON THERAPEUTICS, INC. - CASH WAS $178.8 MILLION AS OF
MARCH
31, 2021
    * SIGILON THERAPEUTICS, INC. QTRLY LOSS PER SHARE $0.60
    * SIGILON THERAPEUTICS - ON TRACK TO FILE CTA AND/OR IND FOR
MPS-1
IN Q2 OF 2021, ANTICIPATES ADDITIONAL REGULATORY FILINGS BEFORE
END OF 2022
    * SIGILON THERAPEUTICS, INC. - EXPECTS TO DISCLOSE UP TO 9
MONTHS
OF FOLLOW UP DATA ON STUDY OF SIG-001 FOR 3-4 PATIENTS IN Q3 OF
2021
    * SIGILON THERAPEUTICS, INC. - FOR STUDY OF SIG-001, EXPECTS
TO
COMPLETE ENROLLMENT OF STUDY IN SECOND HALF OF 2021

Source text for Eikon:  ID:nGNX5dTDH9 
Further company coverage:  SGTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))